Halaman 3 - Radioterapi Dokter Terbaik - TOP-90 dokter

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, dengan 33 tahun pengalaman khusus dalam onkologi dan radioterapi.

• Berspesialisasi dalam Onkologi Medis & Radioterapi
• Dokter senior di Rumah Sakit Universitas Hadassah
• Tersertifikasi dalam Onkologi & Radioterapi
• Anggota Perhimpunan Onkologi Klinis Israel

Dr. Alon Pikarsky memiliki lebih dari 30 tahun keahlian bedah, berspesialisasi dalam bedah kolorektal di Hadassah Medical Center.

• Instruktur Bedah sejak 1995, melatih calon ahli bedah
• Direktur Program Mahasiswa Kedokteran sejak 1997
• Bersertifikat Dewan Israel dalam Bedah Umum sejak 1998
• Anggota berbagai asosiasi bedah sejak 1998

Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz, institusi terkemuka di Turki.

• Bersertifikat dewan dalam onkologi medis sejak 2018
• Lebih dari 15 tahun pengalaman dalam onkologi
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Dr. Gal Goldstein, yang diakui dalam daftar dokter terbaik Forbes, memimpin Departemen Onkologi dan Hemato-Onkologi Pediatrik di Rumah Sakit Hadassah Ein Kerem.

• Lebih dari 20 tahun spesialisasi dalam hemato-onkologi pediatrik dan transplantasi sumsum tulang haploidentik
• Anggota dari berbagai asosiasi onkologi bergengsi termasuk SIOP dan ISPHO
• Fokus pada retinoblastoma dan pengobatan presisi dalam onkologi pediatrik

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Berspesialisasi dalam tumor kepala dan leher serta kanker tiroid dengan teknik radioterapi canggih di Pusat Medis Hadassah.

• Pelatihan dalam bedah radio (radiosurgery) di Memorial Sloan Kettering Cancer Center
• Lebih dari 20 tahun pengalaman dalam onkologi dan radioterapi
• Mantan Kepala Divisi Onkologi Kepala dan Leher di Pusat Kanker Davidoff
• Direktur Departemen Onkologi di Hadassah sejak 2019

Kepala Onkologi Radiasi di Samsung Medical Center – Profesor Lim berspesialisasi dalam kasus kanker kompleks.

• Mendapat pelatihan di Fakultas Kedokteran Universitas Nasional Seoul (Seoul National University College of Medicine)
• Berspesialisasi dalam tumor lambung, pankreatobilier, dan tumor SSP
• Juga menangani tumor pediatrik dan sarkoma
• Menyelesaikan pelatihan spesialis di Samsung Medical Center dan Seoul National University Hospital

Dr. Ahn Jin Seok berspesialisasi dalam radioterapi di Samsung Medical Center, institusi terkemuka untuk pengobatan kanker.

• Onkolog berpengalaman dengan fokus pada terapi radiasi yang presisi
• Bekerja di Samsung Medical Center, yang dikenal karena perawatan kanker canggih
• Berdedikasi pada rencana perawatan yang dipersonalisasi untuk setiap pasien

Dr. Michael Van Kampen berspesialisasi dalam radioterapi di Klinik Nordwest, berfokus pada rencana perawatan yang tepat dan efektif.

• Berpengalaman dalam teknik radioterapi canggih
• Bekerja di Klinik Nordwest – fasilitas terkemuka untuk perawatan kanker
• Berdedikasi pada pendekatan perawatan yang dipersonalisasi

Prof. Myriam Ben Arush adalah spesialis yang diakui secara internasional dalam onkologi pediatrik dan transplantasi sumsum tulang di Rumah Sakit Anak Ruth Rappaport.

• Direktur Divisi Pediatrik di Pusat Medis Rambam
• Penerima Chevalier de la Legion d’Honneur di Prancis
• Dinobatkan sebagai salah satu dokter paling peduli di dunia oleh Asosiasi Medis Dunia
• Anggota kelompok onkologi anak di AS dan perkumpulan kanker Eropa

Dr. Pfeffer berspesialisasi dalam onkologi dan radiologi di Assuta Medical Center, menawarkan perawatan radioterapi bertarget.

• Keahlian ganda dalam onkologi dan radiologi untuk perawatan komprehensif
• Praktik di Assuta Medical Center – fasilitas terkemuka di Israel
• Fokus pada rencana radioterapi yang dipersonalisasi untuk setiap pasien

Dr. Zalmanova berspesialisasi dalam radioterapi di Pusat Medis Assuta, menyediakan perawatan kanker yang ditargetkan.

• Fokus pada pemberian terapi radiasi yang presisi
• Bekerja dengan teknologi radioterapi canggih
• Merupakan bagian dari tim onkologi ternama di Assuta

Dr. Seung Jae Huh adalah seorang onkolog di Samsung Medical Center, dengan spesialisasi di bidang radioterapi.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.